scispace - formally typeset
L

Liping Qiu

Researcher at Hunan University

Publications -  92
Citations -  4431

Liping Qiu is an academic researcher from Hunan University. The author has contributed to research in topics: Aptamer & Medicine. The author has an hindex of 33, co-authored 75 publications receiving 3239 citations. Previous affiliations of Liping Qiu include University of Florida.

Papers
More filters
Journal ArticleDOI

A Nonenzymatic Hairpin DNA Cascade Reaction Provides High Signal Gain of mRNA Imaging inside Live Cells

TL;DR: This programmable cascade reaction presents a simple and modular amplification mechanism for intracellular biomarkers of interest, providing a significant boost to the search for clues leading to the accurate identification and effective treatment of cancers.
Journal ArticleDOI

Building a multifunctional aptamer-based DNA nanoassembly for targeted cancer therapy.

TL;DR: A multifunctional aptamer-based DNA nanoassembly structure able to take advantage of facile modular design and assembly, high programmability, excellent biostability and biocompatibility, as well as selective recognition and transportation shows promise as candidates for targeted drug delivery and cancer therapy.
Journal ArticleDOI

A Cell-Targeted, Size-Photocontrollable, Nuclear-Uptake Nanodrug Delivery System for Drug-Resistant Cancer Therapy

TL;DR: This work has used DNA self-assembly to develop a nuclear-uptake nanodrug system carried by a cell-targeted near-infrared (NIR)-responsive nanotruck for drug-resistant cancer therapy that can efficiently accumulated in the nuclei to effectively kill the cancer cells.
Journal ArticleDOI

DNA probes for monitoring dynamic and transient molecular encounters on live cell membranes

TL;DR: A novel DNA probe is shown that can transduce transient membrane encounter events into readable cumulative fluorescence signals and show a preference for encounters within the same lipid domains.
Journal ArticleDOI

DNA "nano-claw": logic-based autonomous cancer targeting and therapy.

TL;DR: A DNA-based device capable of performing autonomous logic-based analysis of multiple cancer cell-surface markers and, in response, producing a diagnostic signal and/or targeted photodynamic therapy, called "Nano-Claw".